Moderna Stock News

Your 5-minute read to start today: Winds, tornadoes ravage Midwest; Pfizer, Moderna vaccines safest: CDC; server fired over $4K tip.

A Centers for Disease Control and Prevention advisory panel said Thursday that it prefers COVID-19 vaccines made by Moderna and Pfizer over one made by Johnson & Johnson.

Days after the FDA strengthened safety warnings for the company''s shot, a CDC panel recommended Pfizer''s and Moderna''s vaccines be "preferred" over J&J''s.

U.S. health advisers are recommending that most Americans get the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot The post CDC panel recommends Pfizer, Moderna vaccines over J&J shot appeared first on Boston.com .

Pfizer and Moderna COVID-19 vaccines can be used as subsequent doses after initial doses of AstraZeneca and vice versa, the WHO says.

The Johnson & Johnson jab has been linked to a rare clotting problem.

All of these vaccine stocks benefited from rising concerns about the Omicron variant.

With many booked in to receive their Covid-19 boosters, a portion may experience side effects - here are the most common reported ones from the Moderna and Pfizer jabs.

Vaccine advisers to the US Centers for Disease Control and Prevention voted 15-0 Thursday to change recommendations for Covid-19 vaccines to make clear that shots made by Moderna and Pfizer/BioNTech are preferred over Johnson & Johnson''s vaccine.

A CDC advisory panel voted Thursday to recommend that adults receive the Pfizer or Moderna vaccines over the Johnson & Johnson. As reported by Just the News, of the 17 million people who have received the Johnson & Johnson shot, nine people have died after developing a rare blood clotting disorder called thrombosis, per the [] The post CDC Recommends Pfizer, Moderna Vaccines Over Johnson & Johnson appeared first on Human Events .

People in Belgium who received the Pfizer or Moderna coronavirus vaccines will have to wait just four months instead of six to get their booster dose, the government decided on Wednesday evening. The decision will accelerate the booster vaccination campaign and is partly in response to the rapid circulation of the Omicron variant. A government []

That''s the same age range applied to the shot developed by Pfizer Inc and BioNTech, which has been given out about 93,000 times as a booster through Wednesday, taking in about 0.1% of the population. Novavax''s protein-based vaccine was submitted to regulators by its Japanese distributor Takeda Pharmaceutical Co., the company said in a statement.

TOKYO, Dec 16 Japan today officially approved Moderna Inc''s Covid-19 vaccine for its booster shot programme that began this month. The move followed a recommendation from health ministry experts yesterday that Moderna''s mRNA shot, used mostly at

Related Stocks: MRNA , MRVL , CPNG , LOW , SNAP , PDCE , LYB , FIS , A , DDOG , LKQ , PFE , ATVI , TTWO , PH , UNP , PPG , STZ ,

On Dec. 1, 2021, the Federal Circuit held that Moderna lacked standing in an appeal from a Patent Trial and Appeal Board ("PTAB") decision against rival Arbutus where the PTAB determined U.S. Patent No. 9,364,435 ("the ''435 patent") was not unpatentable as obvious.